| Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy P Price, N Mathiot, R Krueger, S Stone, NM Keane, MA French Journal of Clinical Virology 22 (3), 279-287, 2001 | 155 | 2001 |
| Levels of IL‐6 and soluble IL‐6 receptor are increased in HIV patients with a history of immune restoration disease after HAART SF Stone, P Price, NM Keane, RJ Murray, MA French HIV medicine 3 (1), 21-27, 2002 | 130 | 2002 |
| Abacavir-reactive memory T cells are present in drug naive individuals A Lucas, M Lucas, A Strhyn, NM Keane, E McKinnon, R Pavlos, ... PloS one 10 (2), e0117160, 2015 | 90 | 2015 |
| MHC haplotypes affect the expression of opportunistic infections in HIV patients P Price, NM Keane, SF Stone, KYM Cheong, MA French Human immunology 62 (2), 157-164, 2001 | 90 | 2001 |
| Association of increased hepatitis C virus (HCV)–specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral … SF Stone, S Lee, NM Keane, P Price, MA French The Journal of infectious diseases 186 (10), 1498-1502, 2002 | 74 | 2002 |
| HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity NM Keane, RK Pavlos, E McKinnon, A Lucas, C Rive, CC Blyth, D Dunn, ... Aids 28 (13), 1891-1901, 2014 | 66 | 2014 |
| Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5Δ32 allele L Gray, MJ Churchill, N Keane, J Sterjovski, AM Ellett, DFJ Purcell, ... Journal of virology 80 (7), 3684-3691, 2006 | 62 | 2006 |
| An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active … NM Keane, P Price, S Lee, SF Stone, MA French Clinical & Experimental Immunology 126 (1), 111-116, 2001 | 59 | 2001 |
| HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes C Bronke, CAM Almeida, E McKinnon, SG Roberts, NM Keane, A Chopra, ... Aids 27 (6), 899-905, 2013 | 52 | 2013 |
| Susceptibility to opportunistic infections in HIV‐infected patients with increased CD4 T‐cell counts on antiretroviral therapy may be predicted by markers of dysfunctional … MA French, NM Keane, EJ McKinnon, S Phung, P Price Hiv Medicine 8 (3), 148-155, 2007 | 47 | 2007 |
| High‐avidity, high‐IFNγ‐producing CD8 T‐cell responses following immune selection during HIV‐1 infection NM Keane, SG Roberts, CAM Almeida, T Krishnan, A Chopra, E Demaine, ... Immunology and cell biology 90 (2), 224-234, 2012 | 46 | 2012 |
| Restoration of CD4 T‐cell responses to cytomegalovirus is short‐lived in severely immunodeficient HIV‐infected patients responding to highly active antiretroviral therapy NM Keane, P Price, S Lee, CA Almeida, SF Stone, I James, MA French HIV medicine 5 (6), 407-414, 2004 | 44 | 2004 |
| Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy NM Keane, P Price, SF Stone, M John, RJ Murray, MA French AIDS research and human retroviruses 16 (18), 1991-1996, 2000 | 40 | 2000 |
| Interferon-Gamma Responses to Candida Recover Slowly or Remain Low in Immunodeficient HIV Patients Responding to ART K Burgess, P Price, IR James, SF Stone, NM Keane, AYF Lim, ... Journal of Clinical Immunology 26, 160-167, 2006 | 34 | 2006 |
| Translation of HLA–HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against nef and HLA-adapted variant epitopes CAM Almeida, C Bronke, SG Roberts, E McKinnon, NM Keane, A Chopra, ... The Journal of Immunology 187 (5), 2502-2513, 2011 | 31 | 2011 |
| Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses CAM Almeida, SG Roberts, R Laird, E McKinnon, I Ahmed, K Pfafferott, ... Journal of immunological methods 344 (1), 1-5, 2009 | 31 | 2009 |
| Immunological markers predicting outcome in patients with hepatitis C treated with interferon‐α and ribavirin S Lee, GC MacQuillan, NM Keane, J Flexman, GP Jeffrey, MAH French, ... Immunology and cell biology 80 (4), 391-397, 2002 | 24 | 2002 |
| A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy P Price, NM Keane, S Lee, AFY Lim, EJ McKinnon, MA French Immunology 119 (1), 74-82, 2006 | 21 | 2006 |
| Brief Report: CXCR4 or CCR5 Tropism of Human Immunodeficiency Virus Type 1 Isolates Does Not Determine the Immunological Milieu in Patients Responding to … P Price, N Keane, L Gray, S Lee, PR Gorry, MA French Viral immunology 19 (4), 734-740, 2006 | 15 | 2006 |
| Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction E Phillips, A Rauch, D Nolan, A Martin, C Almeida, S Knowles, N Shear, ... 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 2007 | 12 | 2007 |
